News - New Super Bug Threat Met by Ebiox Anti-microbials

August 01 2010

August, 2010- New concerns about antibiotic resistant bacteria producing the enzyme New Delhi Metallo-1 (NDM-1) published recently in the medical journal Lancet Infectious Diseases can be addressed by hospital surgical and sterile services departments through effective use of existing microbiological disinfectants and typical decontamination processes.

According to The Lancet, the current scare relates mainly to gut bacteria such as e-coli and their ability to lead to urinary tract infections or blood poisoning. The study referenced in the article focused on infected surgical sites. Some sites found NDM-1 in gram negative enterobacteriaceae (e-coli) that exhibited resistance to the class of antibiotics known as Carbapenems, which are used when common antibiotics prove ineffective.

“The BBC Online News reviewed the Lancet article, and concluded that normal infection control measures such as cleaning and disinfecting equipment and hand washing are suitable precautions against a spread of the NDM-1 threat,” said Ebiox commercial director Jeff Smith. “As a manufacturer of anti-microbial decontaminants for healthcare use, we are confident that this is solid advice.”

Ebiox TrionicTM and EsenseTM product ranges are proven highly effective against both gram positive and gram negative bacteria present when used as directed on surgical instruments, work surfaces and hands. Further information is available at http://www.ebiox.co.uk. Please direct queries by email to: .(JavaScript must be enabled to view this email address).